Calprotectin, fecal-13385

 

 

Test info

  
Calprotectin, fecal
  
13385
  
LAB13385
  
CALPRF
  

An in vitro diagnostic to aid in the diagnosis of inflammatory bowel disease (IBD), Crohn's disease, and ulcerative colitis, and to differentiate IBD from irritable bowel syndrome (IBS) in conjunction with other clinical and laboratory findings.

Specimen

  
Stool
  
  
1.0 g
  
0.5 g
  
  • Do not contaminate outside of container
  • Do not overfill container
  • Loose stools are acceptable
  

Screw cap plastic container (non sterile)

  

Frozen (preferred) - 4 months

Freeze/Thaw cycles stable x3

Refrigerated  - 3 days

Ambient - 2 days

  
  • Serum or plasma received
  • Stool contaminated with urine
  • Specimen older than 10 days of collection before tested
  • Samples taken from diapers unless portion taken has not been in contact with diaper material
  • Preserved stool

Performance

  
LabCorp Burlington (123255): R-LC
  
Mo - Fr
  
4 - 6 days
  

Quantitative enzyme-linked immunosorbent assay (ELISA)

Clinical and Interpretive info

  

Concentration  

Interpretation    

Follow-up

 < 16 − 50 μg/g

 Normal

 None

 > 50 − 120 μg/g

 Borderline

 Re-evaluate in 4 - 6 weeks

 > 120 μg/g  

 Abnormal

 Repeat as clinically indicated

Billing

  
83993
  
Result 38445-3

Tracking

  
03/27/2019
  
05/31/2023
  
05/31/2023